Michael Coleman

Theratome Bio, Inc. developes an innovative, cell-free secretome concentrate derived from adult adipose stem cells procedure. Its technology solutions will halt brain injury caused by stroke, promote regeneration and repair of brain tissues, and re-establish normal function in animals. The company was founded by Keith March and Yansheng Du in 2011 and is headquartered in Fishers, IN.

Theratome Bio, Inc. developes an innovative, cell-free secretome concentrate derived from adult adipose stem cells procedure. Its technology solutions will halt brain injury caused by stroke, promote regeneration and repair of brain tissues, and re-establish normal function in animals. The company was founded by Keith March and Yansheng Du in 2011 and is headquartered in Fishers, IN.

Theratome Bio, Inc. developes an innovative, cell-free secretome concentrate derived from adult adipose stem cells procedure. Its technology solutions will halt brain injury caused by stroke, promote regeneration and repair of brain tissues, and re-establish normal function in animals. The company was founded by Keith March and Yansheng Du in 2011 and is headquartered in Fishers, IN.

Theratome Bio, Inc. developes an innovative, cell-free secretome concentrate derived from adult adipose stem cells procedure. Its technology solutions will halt brain injury caused by stroke, promote regeneration and repair of brain tissues, and re-establish normal function in animals. The company was founded by Keith March and Yansheng Du in 2011 and is headquartered in Fishers, IN.